Folgen
Anne Laprie
Anne Laprie
Professor ,radiation oncologist, institut claudius regaud, IUCT-oncopole,Tonic INSERM UMR1214, TMBI
Bestätigte E-Mail-Adresse bei iuct-oncopole.fr
Titel
Zitiert von
Zitiert von
Jahr
EANO guidelines for the diagnosis and treatment of ependymal tumors
R Rudà, G Reifenberger, D Frappaz, SM Pfister, A Laprie, T Santarius, ...
Neuro-oncology 20 (4), 445-456, 2018
2532018
Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort
C Klifa, J Carballido-Gamio, L Wilmes, A Laprie, J Shepherd, J Gibbs, ...
Magnetic resonance imaging 28 (1), 8-15, 2010
1412010
Quantification of breast tissue index from MR data using fuzzy clustering
C Klifa, J Carballido-Gamio, L Wilmes, A Laprie, C Lobo, E Demicco, ...
The 26th Annual International Conference of the IEEE Engineering in Medicine …, 2004
1352004
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy
A Laprie, A Pirzkall, DA Haas-Kogan, S Cha, A Banerjee, TP Le, Y Lu, ...
International Journal of Radiation Oncology* Biology* Physics 62 (1), 20-31, 2005
1332005
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study
A Laprie, I Catalaa, E Cassol, TR McKnight, D Berchery, D Marre, ...
International Journal of Radiation Oncology* Biology* Physics 70 (3), 773-781, 2008
1202008
Cardiac diseases following childhood cancer treatment: cohort study
N Haddy, S Diallo, C El-Fayech, B Schwartz, F Pein, M Hawkins, C Veres, ...
Circulation 133 (1), 31-38, 2016
1192016
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost
S Ken, L Vieillevigne, X Franceries, L Simon, C Supper, JA Lotterie, ...
Radiation oncology 8, 1-9, 2013
942013
Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98
C Carrie, J Grill, D Figarella-Branger, V Bernier, L Padovani, JL Habrand, ...
J Clin Oncol 27 (11), 1879-1883, 2009
922009
Paediatric brain tumours: a review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy
A Laprie, Y Hu, C Alapetite, C Carrie, JL Habrand, S Bolle, PY Bondiau, ...
Cancer/Radiothérapie 19 (8), 775-789, 2015
722015
Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
BA Hoeben, C Carrie, B Timmermann, HC Mandeville, L Gandola, ...
The Lancet Oncology 20 (3), e155-e166, 2019
702019
High‐dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with …
A Laprie, J Michon, O Hartmann, C Munzer, MD Leclair, C Coze, ...
Cancer 101 (5), 1081-1089, 2004
622004
Comparison of static and dynamic 18F-FDG PET/CT for quantification of pulmonary inflammation in acute lung injury
A Braune, F Hofheinz, T Bluth, T Kiss, J Wittenstein, M Scharffenberg, ...
Journal of Nuclear Medicine 60 (11), 1629-1634, 2019
59*2019
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme
ECJ Moyal, A Laprie, M Delannes, M Poublanc, I Catalaa, F Dalenc, ...
International Journal of Radiation Oncology* Biology* Physics 68 (5), 1396-1401, 2007
572007
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with …
A Laprie, S Ken, T Filleron, V Lubrano, L Vieillevigne, F Tensaouti, ...
BMC cancer 19, 1-10, 2019
562019
αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I–II clinical trial associating continuous administration of Tipifarnib with …
A Ducassou, E Uro-Coste, P Verrelle, T Filleron, A Benouaich-Amiel, ...
European Journal of Cancer 49 (9), 2161-2169, 2013
552013
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of …
A Deviers, S Ken, T Filleron, B Rowland, A Laruelo, I Catalaa, V Lubrano, ...
International Journal of Radiation Oncology* Biology* Physics 90 (2), 385-393, 2014
542014
Thyroid radiation dose and other risk factors of thyroid carcinoma following childhood cancer
F de Vathaire, N Haddy, RS Allodji, M Hawkins, C Guibout, C El-Fayech, ...
The Journal of Clinical Endocrinology & Metabolism 100 (11), 4282-4290, 2015
492015
The role of radiation therapy in pediatric mucoepidermoid carcinomas of the salivary glands
J Thariat, PO Vedrine, S Temam, AM Ali, D Orbach, G Odin, M Makeieff, ...
The Journal of pediatrics 162 (4), 839-843, 2013
472013
Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment
B Schwartz, MA Benadjaoud, E Cléro, N Haddy, C El-Fayech, C Guibout, ...
Radiation and environmental biophysics 53, 381-390, 2014
452014
Long-term side effects of radiotherapy for pediatric localized neuroblastoma
A Ducassou, M Gambart, CM MScRes, MD Laetitia Padovani, C Carrie, ...
Strahlentherapie und Onkologie 191 (7), 604, 2015
442015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20